OpenURL Connection Search

Select item for more details and to access through your institution.

Open-label trial on efficacy and security of treatment with gemcitabine and oral modulation with tegafur and levofolinic acid (GEMTG) in patients with advanced pancreatic cancer.
Published in:
Clinical & Translational Oncology, 2011, v. 13, n. 1, p. 61, doi. 10.1007/s12094-011-0618-9
By:
- Pericay Pijaume, Carles;
- Escudero Emperador, Pilar;
- Bastús Piulats, Román;
- Campos Cervera, Juan;
- Esquerdo Galiana, Gaspar;
- Gallén Castillo, Manuel;
- Alfaro Gamero, Jordi;
- Dotor Navarro, Emma;
- Pisa Gatell, Aleydis;
- Guasch Jordán, Inmaculada;
- Saigí Grau, Eugeni
Publication type:
Article
Two consecutive studies using oral UFT-based chemotherapy regimens in elderly patients with advanced colorectal cancer.
Published in:
Clinical & Translational Oncology, 2000, v. 2, n. 3, p. 154, doi. 10.1007/BF02979483
By:
- Abad, Albert;
- Aranda, Enrique;
- Navarro, Matilde;
- Carrato, Alfredo;
- Sastre, Javier;
- Gallén, Manuel;
- Marcuello, Eugenio;
- Fernández-Martos, Carlos;
- Cervantes, Andrés;
- Antón, Antonio;
- Rivera, Fernando;
- Massutí, Bertomeu;
- Barneto, Isidoro;
- Guillot, Mónica;
- Díaz-Rubio, Eduardo
Publication type:
Article
Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer.
Published in:
Nature Medicine, 2012, v. 18, n. 9, p. 1445, doi. 10.1038/nm0912-1445b
By:
- Montagut, Clara;
- Dalmases, Alba;
- Bellosillo, Beatriz;
- Crespo, Marta;
- Pairet, Silvia;
- Iglesias, Mar;
- Salido, Marta;
- Gallen, Manuel;
- Marsters, Scot;
- Tsai, Siao Ping;
- Minoche, André;
- Somasekar, Seshagiri;
- Serrano, Sergi;
- Himmelbauer, Heinz;
- Bellmunt, Joaquim;
- Rovira, Ana;
- Settleman, Jeff;
- Bosch, Francesc;
- Albanell, Joan
Publication type:
Article
Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer.
Published in:
Nature Medicine, 2012, v. 18, n. 2, p. 221, doi. 10.1038/nm.2609
By:
- Montagut, Clara;
- Dalmases, Alba;
- Bellosillo, Beatriz;
- Crespo, Marta;
- Pairet, Silvia;
- Iglesias, Mar;
- Salido, Marta;
- Gallen, Manuel;
- Marsters, Scot;
- Tsai, Siao Ping;
- Minoche, André;
- Somasekar, Seshagiri;
- Serrano, Sergi;
- Himmelbauer, Heinz;
- Bellmunt, Joaquim;
- Rovira, Ana;
- Settleman, Jeff;
- Bosch, Francesc;
- Albanell, Joan
Publication type:
Article
Amyloid arthropathy and waldenström's macroglobulinemia.
Published in:
American Journal of Hematology, 1995, v. 49, n. 3, p. 260, doi. 10.1002/ajh.2830490323
By:
- Pedro-Botet, Juan;
- Auguet, Teresa;
- Barranco, Carlos;
- Gallen, Manuel
Publication type:
Article
Prognostic Value of the Combination of Circulating Tumor Cells Plus KRAS in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab.
Published in:
Clinical Colorectal Cancer, 2013, v. 12, n. 4, p. 280, doi. 10.1016/j.clcc.2013.06.001
By:
- Sastre, Javier;
- Vidaurreta, Marta;
- Gómez, Auxiliadora;
- Rivera, Fernando;
- Massutí, Bartomeu;
- López, Margarita Reboredo;
- Abad, Albert;
- Gallen, Manuel;
- Benavides, Manuel;
- Aranda, Enrique;
- Rubio, Eduardo Díaz
Publication type:
Article
Circulating Tumor Cell Count Is a Prognostic Factor in Metastatic Colorectal Cancer Patients Receiving First-Line Chemotherapy Plus Bevacizumab: A Spanish Cooperative Group for the Treatment of Digestive Tumors Study.
Published in:
Oncologist, 2012, v. 17, n. 7, p. 947, doi. 10.1634/theoncologist.2012-0048
By:
- SASTRE, JAVIER;
- MAESTRO, M. LUISA;
- GÓMEZ-ESPAÑA, AUXILIADORA;
- RIVERA, FERNANDO;
- VALLADARES, MANUEL;
- MASSUTI, BARTOMEU;
- BENAVIDES, MANUEL;
- GALLÉN, MANUEL;
- MARCUELLO, EUGENIO;
- ABAD, ALBERT;
- ARRIVI, ANTONIO;
- FERNÁNDEZ-MARTOS, CARLOS;
- GONZÁLEZ, ENCARNACIÓN;
- TABERNERO, JOSEP M.;
- VIDAURRETA, MARTA;
- ARANDA, ENRIQUE;
- DÍAZ-RUBIO, EDUARDO
Publication type:
Article

Found: 7

Open-label trial on efficacy and security of treatment with gemcitabine and oral modulation with tegafur and levofolinic acid (GEMTG) in patients with advanced pancreatic cancer.

Two consecutive studies using oral UFT-based chemotherapy regimens in elderly patients with advanced colorectal cancer.

Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer.

Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer.

Amyloid arthropathy and waldenström's macroglobulinemia.

Prognostic Value of the Combination of Circulating Tumor Cells Plus KRAS in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab.

Circulating Tumor Cell Count Is a Prognostic Factor in Metastatic Colorectal Cancer Patients Receiving First-Line Chemotherapy Plus Bevacizumab: A Spanish Cooperative Group for the Treatment of Digestive Tumors Study.